06:23duration 6 minutes 23 seconds
APOLLO Trial Finds Experimental ‘Gene…
APOLLO Trial Finds Experimental ‘Gene Silencing’ Therapy Reduces Lipoprotein(a) By Up To 98%
Presented at ACC as a Late-Breaking Clinical Trial, the Cleveland Clinic-led APOLLO trial explores siRNA therapy as a treatment option to help prevent premature heart disease in people with high…